Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center

BACKGROUND: Whether nab-paclitaxel plus carboplatin as neoadjuvant therapy can benefit patients with resectable squamous cell carcinoma of the lung remains unclear. This prospective study aimed to investigate outcomes in patients with stage IIIA-N2 squamous cell carcinoma of the lung treated with na...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jianquan, Zhang, Yu, Wang, Meng, Zhang, Zhenfa, Yue, Dongsheng, Liu, Shichang, Pan, Yi, Wang, Changli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366304/
https://www.ncbi.nlm.nih.gov/pubmed/34376631
http://dx.doi.org/10.12659/MSM.930738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366304/
https://www.ncbi.nlm.nih.gov/pubmed/34376631
http://dx.doi.org/10.12659/MSM.930738

Ejemplares similares